Views & Analysis | Perspectives on pharma industry issues

Oncology

Liquid biopsy and the future of tumour-agnostic treatments

Liquid biopsy-based tools are positioned as a critical enabler of tumour-agnostic therapeutic development.

Digital

Google AI Overviews: What it means for pharma

EVERSANA INTOUCH’s 2026 Pharma AI Overviews Report covers the rapid evolution within the Google AI Overviews landscape.

R&D

Clinical Trials Round-Up: March and April 2026

March and April offered no shortage of talking points for the clinical trials community.

Sales & Marketing

Sponsored

12 Questions with Shauna Lord

Shauna Lord recently joined GSK as Business Unit Head Specialty (UK Commercial) to lead the Specialty business in the UK.

Digital

HCP holds agenticc AI in open palmed hand against dark background

Veeva Agentic Commercial: Evidence‑led AI for pharma

Veeva's Commercial Cloud aims to deliver the right medicines to more patients.

Views & Analysis

The state of personalised medicine in 2019

Things are good, and they’re getting better.

Views & Analysis

How new technologies are creating new markets

Sarah Rickwood looks at why the next frontier for pharmaceutical innovation may not be a pharmaceutical at all, and how this will affect launch

Views & Analysis

ESMO 2019 roundup

The European Society for Medical Oncology (ESMO) is growing in stature, with an increasing number of oncology-focused pharma companies choosing it as a forum to reveal their latest studies.

Sales & Marketing

Sponsored

12 Questions with Shauna Lord

Shauna Lord recently joined GSK as Business Unit Head Specialty (UK Commercial) to lead the Specialty business in the UK.

Sales & Marketing

Sponsored

Solution Spotlight: IQVIA CTFS Site Payments

IQVIA Clinical Trial Financial Suite (CTFS) is a next-generation platform designed to modernise clinical trial financial operations.

Digital

Google AI Overviews: What it means for pharma

EVERSANA INTOUCH’s 2026 Pharma AI Overviews Report covers the rapid evolution within the Google AI Overviews landscape.

Digital

Veeva Agentic Commercial: Evidence‑led AI for pharma

Veeva's Commercial Cloud aims to deliver the right medicines to more patients.

Market Access

Industry exercises option for midpoint review of VPAG Invest...

Under the VPAG agreement, £400 million is available under the VPAG Investment Fund. But what benefits will stay once funding goes away in 2029?

Market Access

Approval designed from day one: Building global-ready regula...

The global pharmaceutical landscape is increasingly defined by the necessity for clinical acceleration without compromising data integrity.

Oncology

ASCO 2026: AbbVie on ADCs, chemotherapy, and the future of o...

For years, ADCs have been positioned as an important addition to the oncology toolkit. But, could they eventually replace chemotherapy altogether?

Oncology

Liquid biopsy and the future of tumour-agnostic treatments

Liquid biopsy-based tools are positioned as a critical enabler of tumour-agnostic therapeutic development.

Oncology

pharmaphorum podcast Episode 264, ITM's Dr Andrew Cavey

Radiopharma in 2026 & beyond, with ITM's Dr Andrew Cavey

Dr Andrew Cavey, CEO of ITM, discusses current and future radiopharmaceutical trends.

Patients

Patient centricity beyond buzzwords: What works

There is a strong emphasis on patient centricity, but, in many cases, patient engagement is just used to validate pre-existing assumptions.

Patients

Pharmacy sign with yellow townhouse in background

Community pharmacy is ready to lead. Now it needs the system...

Community pharmacy is the infrastructure that makes NHS long-term plans and ambitions possible. But infrastructure without investment does not hold.

Patients

Stem the bleeding: Rising to meet the growing demand for CGT...

Following World Blood Donor Day, a look at the continued need for more donors of blood, but also cord blood and perinatal tissue, too.

R&D

Clinical Trials Round-Up: March and April 2026

March and April offered no shortage of talking points for the clinical trials community.

R&D

Stethoscope rests on medical textbook with AI concept overlay, light blue background

Medical education: Bridging science and clinical practice

Emily Harrison, founder and managing director of Nexus Healthcare Education, explains the critical role medical education plays.

R&D

Sponsored

The UK life sciences sector at a crossroads: Bold decisions ...

We all want the same thing: for the UK to succeed, for our workforces to thrive, and for patients and the NHS to benefit.

Sales & Marketing

Digital

Market Access

Editor's Picks

Oncology

Patients

R&D

Editor's Picks